Innovative Care for Children and Adolescents with Severe and/or Genetic Obesity

2.

Zolotarjova

J

,

Ten Velde

G

,

Vreugdenhil

ACE

.

Effects of multidisciplinary interventions on weight loss and health outcomes in children and adolescents with morbid obesity

.

Obes Rev

.

2018

;

19

(

7

):

931

–

46

.

3.

Spinelli

A

,

Buoncristiano

M

,

Kovacs

VA

,

Yngve

A

,

Spiroski

I

,

Obreja

G

, et al.

Prevalence of severe obesity among primary school children in 21 European countries

.

Obes Facts

.

2019

;

12

(

2

):

244

–

58

.

4.

Hales

CM

,

Fryar

CD

,

Carroll

MD

,

Freedman

DS

,

Ogden

CL

.

Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007-2008 to 2015-2016

.

JAMA

.

2018

;

319

(

16

):

1723

–

5

.

5.

Geserick

M

,

Vogel

M

,

Gausche

R

,

Lipek

T

,

Spielau

U

,

Keller

E

, et al.

Acceleration of BMI in early childhood and risk of sustained obesity

.

N Engl J Med

.

2018

;

379

(

14

):

1303

–

12

.

6.

Wabitsch

M

,

V Schnurbein

J

,

Vollbach

H

,

Lennerz

B

,

Weyhreter

H

,

Wiegand

S

, et al.

[Innovative medical care concepts for adolescents with severe obesity]

.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz

.

2020

;

63

:

831

–

8

.

7.

Loos

RJF

,

Yeo

GSH

.

The genetics of obesity: from discovery to biology

.

Nat Rev Genet

.

2022

;

23

(

2

):

120

–

33

.

8.

Baldini

G

,

Phelan

KD

.

The melanocortin pathway and control of appetite-progress and therapeutic implications

.

J Endocrinol

.

2019

;

241

(

1

):

R1

–

33

.

9.

Farooqi

IS

,

Wangensteen

T

,

Collins

S

,

Kimber

W

,

Matarese

G

,

Keogh

JM

, et al.

Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor

.

N Engl J Med

.

2007

;

356

(

3

):

237

–

47

.

10.

Kleinendorst

L

,

Massink

MPG

,

Cooiman

MI

,

Savas

M

,

van der Baan-Slootweg

OH

,

Roelants

RJ

, et al.

Genetic obesity: next-generation sequencing results of 1230 patients with obesity

.

J Med Genet

.

2018

;

55

(

9

):

578

–

86

.

11.

Courbage

S

,

Poitou

C

,

Le Beyec-Le Bihan

J

,

Karsenty

A

,

Lemale

J

,

Pelloux

V

, et al.

Implication of heterozygous variants in genes of the leptin-melanocortin pathway in severe obesity

.

J Clin Endocrinol Metab

.

2021

;

106

(

10

):

2991

–

3006

.

12.

Wade

KH

,

Lam

BYH

,

Melvin

A

,

Pan

W

,

Corbin

LJ

,

Hughes

DA

, et al.

Loss-of-function mutations in the melanocortin 4 receptor in a UK birth cohort

.

Nat Med

.

2021

;

27

(

6

):

1088

–

96

.

13.

Farooqi

IS

,

O’Rahilly

S

.

The genetics of obesity in humans

. In:

Feingold

KR

,

Anawalt

B

,

Blackman

MR

,

Boyce

A

,

Chrousos

G

,

Corpas

E

, et al, editors.

Hrsg. Endotext

.

South Dartmouth, MA

:

MDText.com, Inc.

;

2000

.

14.

Galler

A

,

Thönnes

A

,

Joas

J

,

Joisten

C

,

Körner

A

,

Reinehr

T

, et al.

Clinical characteristics and outcomes of children, adolescents and young adults with overweight or obesity and mental health disorders

.

Int J Obes

.

2024

;

48

(

3

):

423

–

32

.

15.

Varela

C

,

Andrés

A

,

Saldaña

C

.

The behavioral pathway model to overweight and obesity: coping strategies, eating behaviors and body mass index

.

Eat Weight Disord

.

2020

;

25

(

5

):

1277

–

83

.

16.

Latner

JD

,

Stunkard

AJ

.

Getting worse: the stigmatization of obese children

.

Obes Res

.

2003

;

11

(

3

):

452

–

6

.

17.

Westbury

S

,

Oyebode

O

,

van Rens

T

,

Barber

TM

.

Obesity stigma: causes, consequences, and potential solutions

.

Curr Obes Rep

.

2023

;

12

(

1

):

10

–

23

.

18.

Sarwer

DB

,

Polonsky

HM

.

The psychosocial burden of obesity

.

Endocrinol Metab Clin North Am

.

2016

;

45

(

3

):

677

–

88

.

19.

Danielsson

P

,

Kowalski

J

,

Ekblom

Ö

,

Marcus

C

.

Response of severely obese children and adolescents to behavioral treatment

.

Arch Pediatr Adolesc Med

.

2012

;

166

(

12

):

1103

–

8

.

20.

Lennerz

BS

,

Moss

A

,

von Schnurbein

J

,

Bickenbach

A

,

Bollow

E

,

Brandt

S

, et al.

Do adolescents with extreme obesity differ according to previous treatment seeking behavior? The Youth with Extreme obesity Study (YES) cohort

.

Int J Obes

.

2019

;

43

(

1

):

103

–

15

.

21.

Lister

NB

,

Baur

LA

,

Felix

JF

,

Hill

AJ

,

Marcus

C

,

Reinehr

T

, et al.

Child and adolescent obesity

.

Nat Rev Dis Primers

.

2023

;

9

(

1

):

24

.

22.

Colquitt

JL

,

Loveman

E

,

O'Malley

C

,

Azevedo

LB

,

Mead

E

,

Al-Khudairy

L

, et al.

Diet, physical activity, and behavioural interventions for the treatment of overweight or obesity in preschool children up to the age of 6 years

.

Cochrane Database Syst Rev

.

2016

;

3

:

CD012105

.

23.

Mead

E

,

Brown

T

,

Rees

K

,

Azevedo

LB

,

Whittaker

V

,

Jones

D

, et al.

Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years

.

Cochrane Database Syst Rev

.

2017

;

6

:

CD012651

.

24.

Al-Khudairy

L

,

Loveman

E

,

Colquitt

JL

,

Mead

E

,

Johnson

RE

,

Fraser

H

, et al.

Diet, physical activity and behavioural interventions for the treatment of overweight or obese adolescents aged 12 to 17 years

.

Cochrane Database Syst Rev

.

2017

;

6

:

CD012691

.

25.

Knop

C

,

Singer

V

,

Uysal

Y

,

Schaefer

A

,

Wolters

B

,

Reinehr

T

.

Extremely obese children respond better than extremely obese adolescents to lifestyle interventions

.

Pediatr Obes

.

2015

;

10

(

1

):

7

–

14

.

26.

Reinehr

T

,

Hebebrand

J

,

Friedel

S

,

Toschke

AM

,

Brumm

H

,

Biebermann

H

, et al.

Lifestyle intervention in obese children with variations in the melanocortin 4 receptor gene

.

Obesity

.

2009

;

17

(

2

):

382

–

9

.

27.

Wabitsch

M

,

Farooqi

S

,

Flück

CE

,

Bratina

N

,

Mallya

UG

,

Stewart

M

, et al.

Natural history of obesity due to POMC, PCSK1, and LEPR deficiency and the impact of setmelanotide

.

J Endocr Soc

.

2022

;

6

:

bvac057

.

28.

Sonntag

D

,

Ali

S

,

De Bock

F

.

Lifetime indirect cost of childhood overweight and obesity: a decision analytic model

.

Obesity

.

2016

;

24

(

1

):

200

–

6

.

29.

Weghuber

D

,

Barrett

T

,

Barrientos-Pérez

M

,

Gies

I

,

Hesse

D

,

Jeppesen

OK

, et al.

Once-weekly Semaglutide in adolescents with obesity

.

N Engl J Med

.

2022

;

387

(

24

):

2245

–

57

.

30.

Kelly

AS

,

Auerbach

P

,

Barrientos-Perez

M

,

Gies

I

,

Hale

PM

,

Marcus

C

, et al.

A randomized, controlled trial of Liraglutide for adolescents with obesity

.

N Engl J Med

.

2020

;

382

(

22

):

2117

–

28

.

31.

Fox

CK

,

Barrientos-Pérez

M

,

Bomberg

EM

,

Dcruz

J

,

Gies

I

,

Harder-Lauridsen

NM

, et al.

Liraglutide for children 6 to <12 years of age with obesity - a randomized trial

.

N Engl J Med

.

2024

;

392

(

6

):

555

–

65

.

32.

Iepsen

EW

,

Zhang

J

,

Thomsen

HS

,

Hansen

EL

,

Hollensted

M

,

Madsbad

S

, et al.

Patients with obesity caused by melanocortin-4 receptor mutations can Be treated with a glucagon-like peptide-1 receptor agonist

.

Cell Metab

.

2018

;

28

(

1

):

23

–

32.e3

.

33.

Welling

MS

,

de Groot

CJ

,

Kleinendorst

L

,

van der Voorn

B

,

Burgerhart

JS

,

van der Valk

ES

, et al.

Effects of glucagon-like peptide-1 analogue treatment in genetic obesity: a case series

.

Clin Obes

.

2021

;

11

(

6

):

e12481

.

34.

Iepsen

EW

,

Have

CT

,

Veedfald

S

,

Madsbad

S

,

Holst

JJ

,

Grarup

N

, et al.

GLP-1 receptor agonist treatment in morbid obesity and type 2 diabetes due to pathogenic homozygous melanocortin-4 receptor mutation: a case report

.

Cell Rep Med

.

2020

;

1

:

100006

.

35.

Kusminski

CM

,

Perez-Tilve

D

,

Müller

TD

et al.

Transforming obesity: The advancement of multi-receptor drugs

.

Cell

.

2024

;

187

(

15

):

3829

–

53

.

36.

Farooqi

IS

,

Matarese

G

,

Lord

GM

,

Keogh

JM

,

Lawrence

E

,

Agwu

C

, et al.

Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency

.

J Clin Investig

.

2002

;

110

(

8

):

1093

–

103

.

37.

Clément

K

,

van den Akker

E

,

Argente

J

,

Bahm

A

,

Chung

WK

,

Connors

H

, et al.

Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials

.

Lancet Diabetes Endocrinol

.

2020

;

8

(

12

):

960

–

70

.

38.

Haqq

AM

,

Chung

WK

,

Dollfus

H

,

Haws

RM

,

Martos-Moreno

GÁ

,

Poitou

C

, et al.

Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period

.

Lancet Diabetes Endocrinol

.

2022

;

10

(

12

):

859

–

68

.

39.

Inge

TH

,

Courcoulas

AP

,

Jenkins

TM

,

Michalsky

MP

,

Helmrath

MA

,

Brandt

ML

, et al.

Weight loss and health status 3 years after bariatric surgery in adolescents

.

N Engl J Med

.

2016

;

374

(

2

):

113

–

23

.

40.

Olbers

T

,

Beamish

AJ

,

Gronowitz

E

,

Flodmark

CE

,

Dahlgren

J

,

Bruze

G

, et al.

Laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity (AMOS): a prospective, 5-year, Swedish nationwide study

.

Lancet Diabetes Endocrinol

.

2017

;

5

(

3

):

174

–

83

.

41.

Brandt

S

,

Lennerz

BS

,

Wiegand

S

,

Schirmer

M

,

Kleger

P

,

Weyhreter

H

, et al.

Twelve-month outcomes after metabolic and bariatric surgery among youths participating in a structured preparation and follow-up program: results of the youth with extreme obesity study

.

Obes Facts

.

2024

;

17

(

1

):

59

–

71

.

42.

Cooiman

MI

,

Kleinendorst

L

,

Aarts

EO

,

Janssen

IMC

,

van Amstel

HKP

,

Blakemore

AI

, et al.

Genetic obesity and bariatric surgery outcome in 1014 patients with morbid obesity

.

Obes Surg

.

2020

;

30

(

2

):

470

–

7

.

43.

Poitou

C

,

Puder

L

,

Dubern

B

,

Krabusch

P

,

Genser

L

,

Wiegand

S

, et al.

Long-term outcomes of bariatric surgery in patients with bi-allelic mutations in the POMC, LEPR, and MC4R genes

.

Surg Obes Relat Dis

.

2021

;

17

(

8

):

1449

–

56

.

44.

Zorn

S

,

Schirmer

M

,

von Schnurbein

J

,

Brandt

S

,

Göpel

E

,

Stein

R

, et al.

Versorgungskonzepte für Kinder und Jugendliche mit extremer und/oder genetischer Adipositas

.

Adipositas – Ursachen, Folgeerkrankungen, Therapie

.

2024

;

18

(

02

):

71

–

80

.